Hartman Institute for Therapeutic Organ Regeneration

Publications

Found 21 results
Author Title Type [ Year(Desc)]
Filters: Author is Rafii, Arash  [Clear All Filters]
2014
Guerrouahen BS, Pasquier J, Kaoud NAbu, Maleki M, Beauchamp M-C, Yasmeen A, Ghiabi P, Lis R, Vidal F, Saleh A et al..  2014.  Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer.. Mol Cancer Ther. 13(12):3123-36.
Cao Z, Ding B-S, Guo P, Lee SB, Butler JM, Casey SC, Simons M, Tam W, Felsher DW, Shido K et al..  2014.  Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance.. Cancer Cell. 25(3):350-65.
Ghiabi P, Jiang J, Pasquier J, Maleki M, Abu-Kaoud N, Rafii S, Rafii A.  2014.  Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties.. PLoS One. 9(11):e112424.
Lis R, Touboul C, Halabi NM, Madduri ASainath, Querleu D, Mezey J, Malek JA, Suhre K, Rafii A.  2014.  Mesenchymal cell interaction with ovarian cancer cells induces a background dependent pro-metastatic transcriptomic profile.. J Transl Med. 12:59.
Pasquier J, Thawadi HAl, Ghiabi P, Abu-Kaoud N, Maleki M, Guerrouahen BS, Vidal F, Courderc B, Ferron G, Martinez A et al..  2014.  Microparticles mediated cross-talk between tumoral and endothelial cells promote the constitution of a pro-metastatic vascular niche through Arf6 up regulation.. Cancer Microenviron. 7(1-2):41-59.
Touboul C, Vidal F, Pasquier J, Lis R, Rafii A.  2014.  Role of mesenchymal cells in the natural history of ovarian cancer: a review.. J Transl Med. 12:271.